Consistently, SA-β-gal staining results manifested that the proportion of senescent GIST-T1 cells after silencing EZH2 was severely enhanced, which was annulled by sh-TET1 treatment (Fig. 4C). The gene discussed is TET1; the disease is gastrointestinal stromal tumor.